World Health Organization Endorses Oxford's Life-Saving Malaria Vaccine
TL;DR
Novavax's Matrix-M adjuvant, licensed to the Serum Institute of India (SII), is a key ingredient in the second-ever malaria vaccine endorsed by the World Health Organization. The vaccine, called R21/Matrix-M, will help address the high demand for malaria vaccines in Africa. SII, the world's largest vaccine producer, is already producing doses and plans to scale up to 200 million doses over the next two years. The Serum Institute has also partnered with Aspen Pharmacare to produce multiple vaccines in Africa, contributing to the continent's self-reliance in vaccine manufacturing.
Topics:top-newshealth#africa#health#malaria-vaccine#novavax#serum-institute-of-india#world-health-organization
- Behind the new malaria vaccine endorsed by the World Health Organization Yahoo Finance
- The Guardian view on malaria vaccines: life-saving tools that are sorely needed The Guardian
- New malaria vaccine “could save millions of lives” - BBC News BBC News
- Oxford’s new malaria R21/Matrix-M vaccine approved by WHO The Washington Post
Want the full story? Read the original reporting
Read on Yahoo Finance